Saint-Alexis de Montcalm, Canada

Daniel Lafontaine


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Lafontaine

Introduction

Daniel Lafontaine is a notable inventor based in Saint-Alexis de Montcalm, Canada. He has made significant contributions to the field of molecular biology through his innovative work on nucleic acid enzymes. His research focuses on methods for cleaving nucleic acid substrates, which has important implications in genetic research and biotechnology.

Latest Patents

Lafontaine holds a patent for a nucleic acid enzyme designed for RNA cleavage. This patent describes a method that involves mixing a nucleic acid substrate with an enzyme at a specific cleavage site. The substrate includes a unique 7 nucleotide sequence that facilitates the cleavage process. The enzyme is engineered to bind to the substrate effectively, ensuring precise cleavage at the designated site. This invention represents a significant advancement in the tools available for genetic manipulation and analysis.

Career Highlights

Daniel Lafontaine is affiliated with the Université de Sherbrooke, where he conducts his research and development activities. His work has garnered attention for its potential applications in various fields, including medicine and genetic engineering. With a focus on innovative solutions, Lafontaine continues to push the boundaries of what is possible in molecular biology.

Collaborations

Lafontaine has collaborated with esteemed colleagues such as Jean-Pierre Perreault and Sirinart Ananvoranich. These partnerships have enriched his research and contributed to the advancement of their collective work in the field.

Conclusion

Daniel Lafontaine's contributions to the field of molecular biology through his innovative patent on nucleic acid enzymes highlight the importance of research and collaboration in driving scientific progress. His work continues to inspire future innovations in genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…